Mitoxantrone Completed Phase 2 Trials for Recurrent Prostate Cancer / Stage IV Prostate Cancer / Adenocarcinoma of the Prostate Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00058084Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer